The National Alkaptonuria Centre 


 

Many people diagnosed with alkaptonuria (AKU), have difficulty accessing efficient and effective care to treat their AKU. For some, there has been a lack of local expertise and knowledge when dealing with such a rare disease, resulting in the failure to detect complications of AKU and an inability to make appropriate treatments available.

The Robert Gregory National Alkaptonuria Centre exists to change this. It is needed to ensure that everyone with AKU has access to a knowledgeable team of specialists who can manage their care efficiently. 

The National AKU Centre was established by the Department of Health (National Specialised Services Commissioning Group) and opened to patients on 18th June 2012. The service was set up to provide assessments and treatment for people with AKU and is based at The Royal Liverpool University Hospital. It is a free NHS service open to anyone over the age of 16 who has been diagnosed with AKU and living in England or Scotland.

Patients who attend the National AKU Centre will receive: 

  • A full health assessment and treatment of AKU
  • Access to the drug nitisinone
  • Advice on living with and managing the disease.

Referral to The National AKU Centre

Once a diagnosis of AKU has been confirmed a GP or other relevant medical professional can make a referral to the National Centre. Diagnosis is confirmed by measuring the homogentisic acid levels in a blood or urine test. The referral is assessed by the team in Liverpool and the person is then invited to attend the National Centre.

The National AKU Centre can accommodate up to five patients per month and anyone attending is expected to return for review on an annual basis at the same time each year. The average stay at the Centre is three to four days.

Referrals from Wales

Wales has its own referral process for accessing the NAC. In the first instance, a GP or relevant physician must follow the appropriate clinical gateway. For AKU, a person has to be referred to the Clinical Gatekeeper based at Cardiff University Hospital. He will determine whether the specialist services needed to meet an individual’s needs is available in Wales. If it is deemed that such services are not available a referral to the NAC is agreed and the Gatekeeper will apply to the Welsh Health Specialised Services Committee for funding. If funding is agreed, the Gatekeeper can make a direct referral to the NAC.

Nitisinone is a drug currently licensed for another rare disease and it is thought to be effective in treating patients with AKU. All English and Scottish patients who attend the National AKU Centre are given access to nitisinone. At this time funding for patients in Wales and Northern Ireland is not available for accessing nitisinone.

If you would like to know more about the National Alkaptonuria Centre, please contact Lesley Harrison by emailing her at lesley@akusociety.org or giving her a call on 07586759028. 

Published: 24.07.16 Next Review Date: 24.07.19


 



AKU Twitter

AKU Blog

Farewell from Rory and Robin
25-Jul-2017

In today’s blog, we hear from Rory and Robin who are both leaving the AKU Society for pastures.. ...more

Meet the patient - Antony Kelly
19-Jul-2017

In this week’s blog, we speak to AKU patient Antony Kelly. Antony has been kind enough to tell.. ...more

Farewell from Oliver
11-Jul-2017

Oliver has worked at the AKU Society for the last 7 years, and has been CEO for the last 2. At t.. ...more

Stand Up For AKU Night 2017
05-Jul-2017

On Thursday, June 29th, Robin and Lesley travelled up to Liverpool for the 2017 Stand Up For AK.. ...more

Spartan Race 2017 : Meet the Runners
28-Jun-2017

On September 3rd the AKU Society will have 6 runners in the 2017 Spartan Race. This.. ...more